Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Utilizzo di ROSA per sfidare lo standard di cura TKA

Sfidare lo standard di cura della TKA: obiettivi chirurgici specifici per il paziente come consentito da Rosa

This is a prospective, randomized controlled trial using the cruciate retaining, MC Persona to comparing the conventional TKA to ROSA assisted TKA. Patients will be randomized to one of three study trial arms.

  1. Standard of care medial parapetallar approach (Control)
  2. ROSA PSA medial parapetallar approach
  3. ROSA PSA medial subvastus approach Participants will be followed for 1 year post surgery with a combination of perioperative parameters, imaging, patient reported outcomes, functional outcomes, blood and tissue sampling for inflammatory information and activity levels.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Total knee arthroplasty (TKA) is performed to treat end-stage arthropathy of the knee with substantial increases in surgical volumes projected from the existing 750,000 surgeries performed in North America annually. The current standard of care for a primary TKA is a medial parapatellar exposure with the surgical objective of a mechanically neutral limb alignment, with the tibial component perpendicular to the anatomic axis of the tibia. As patient dissatisfaction in their TKA is substantial, surgeons, allied health care workers and patients continue to work to optimize the outcomes by tailoring surgical approaches to patient specific characteristics, with a goal to diminish early and post-operative causes of dissatisfaction. As patient-reported functional outcomes scores are an important contributor of dissatisfaction, understanding how surgical objectives and technology affect measurable functional outcomes, patient-reported outcomes, health economic and inflammatory response is important.

One of the developing thoughts in TKA surgery has been the elucidation of the range of native alignment of patients' anatomy. As placing TKA components in positions dictated by the patient's unique anatomy has garnered greater attention, literature has suggested that respecting the patient's native anatomy of joint alignment may result in equivalent or possibly improved functional outcome scores compared to neutral mechanical alignment. Simultaneously, concerns have been raised that substantial varus alignment will inadvertently occur, with resultant negative impact on longevity. A more directive patient specific alignment (PSA) concept is the anatomic alignment approach that is built around the objective of achieving a 3 degree varus joint line with respect to the mechanical axis of the leg. It is thought that this may improve patient satisfaction and function as the anatomy of the joint is preserved, including improved soft tissue balance with less soft tissue releases required. However, as conventional instrumentation is imprecise and its use can result in a range of component alignments, a surgical objective of slight varus has a substantial risk of having the implants in too great of joint line angulation resulting in reduced longevity. Improved surgical instrumentation is required to enable PSA with the objective of precisely attaining anatomic alignment to avoid the negative effect of overly varus alignment.

Zimmer-Biomet has introduced the unique ROSA orthopaedic robot. This surgical instrument will enable the surgeon to easily achieve surgical objectives with greater precision than conventional techniques. In contrast with the market leader in orthopaedic robotic assistance, the ROSA also enables the surgeon to be flexible with surgical approach and potentiate intraoperative decision making by providing greater information intra-operatively. It also enables image or imageless care pathways to enable surgeons to do surgical planning themselves to create unique surgical objectives for each patient. These market differentiating features of this orthopaedic robot advance orthopaedic care and provide the basis of expanding the orthopaedic community's understanding of PSA. The robot will also enable further challenges to the current standard of care TKA. For example, quadriceps sparing approaches such as the subvastus approach have been demonstrated to improve early functional recovery but has also been suggested to have higher rates of implant malalignment. The flexibility of approach as well as the precision of the ROSA will potentiate this approach for enhanced recovery programs, which are important in this time of increased health care burdens with limited resources as well as demands for outpatient procedures. Finally, as the Persona ® MC potentiates physiologic function of the knee with a medial pivot point rather than non-physiologic kinematics of many other TKA designs, the knee potentially will feel more physiologic. As objective and subjective functional outcomes are substantial contributors to patient dissatisfaction, understanding how patient specific alignment and soft tissue sparing approaches might improve functional outcome is critical. Wearable technology, another recent advancement within orthopaedics, has demonstrable ability to measure innumerable functional variables, and will enable a greater understanding of how the ROSA in combination with the Persona MC will lead to improved outcomes and reduced resource use.

Current literature has used inflammatory response to assess the decreased amount of soft tissue disruption after robotic versus conventional TKA. Since objective and subjective joint stiffness and reduced range of motion are common complaints among patients with suboptimal outcomes after TKA, The investigators will examine knee inflammation and fibrosis as these likely contribute to stiffness. Understanding the effect of PSA ROSA TKA with the Persona MC on local and systemic inflammation both early post-operatively as well as at one year post-operatively will be achieved by advanced imaging as well as systemic markers in the context of each individual patient's unique cellular characteristics. Our proposal will also enable quantification of how soft tissue preserving approaches affect the local inflammatory response as well as muscle atrophy or edema.

Patient reported outcome measures (PROMs) are an important subjective metric to measure surgical success and traditionally have been the primary outcome measure for many studies. However, PROMs are limited by the multi-factorial nature of the measure as well as limited responsiveness and substantial ceiling effect. The improved data collection of wearable technology has enabled differentiation of factors influencing patient satisfaction with smaller numbers of patients. Because of this, wearable technology has several advantages as a primary outcome, including the fact that wearable technology directly measures functional outcomes: a primary source of dissatisfaction after a TKA. As restoration of the patient's anatomy within defined limits should enable the implant to function with greater harmony within the envelope of static and dynamic soft tissues, functional outcomes will be the primary outcome of this proposed randomized control trial (RCT).

The investigators propose in this prospective RCT to randomize 90 patients to one of three trial arms. The control trial arm will be the standard of care TKA Persona MC and be compared to PSA ROSA TKA with the Persona MC experimental arms of two different surgical exposures. The purpose is to examine the trajectory of functional recovery as well as PROMs and inflammatory response of standard of care TKA compared to outcomes enabled by the ROSA with the objective of improving care for TKA patients.

Tipo di studio

Interventistico

Iscrizione (Stimato)

90

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Ontario
      • London, Ontario, Canada
        • Reclutamento
        • University Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 21 anni a 80 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty
  • Varus knee deformity of 0 to 10 degrees
  • Sufficient ligamentous function to warrant retention of the posterior cruciate ligament
  • Between the ages of 21 and 80 inclusive
  • Patients willing and able to comply with follow-up requirements and self-evaluations
  • Ability to give informed consent

Exclusion Criteria:

  • Active or prior infection
  • Medical condition precluding major surgery
  • Predominantly inflammatory arthropathy
  • Patellectomy
  • PCL deficiency
  • Major coronal plane deformity
  • Prior trauma to the tibia or femur resulting in malalignment, canal occlusion, or open reduction and internal fixation
  • Valgus alignment
  • Neurologic condition limiting mobility
  • Bone defects requiring augments, cones and/or stemmed implants
  • Intraoperative findings of insufficient contact between the implant and the bone surface
  • Body Mass Index of 40 or more

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Control

Standard of care medial parapetallar approach

Comparatore attivo: ROSA PSA Parapatellar Approach

Arm using the ROSA with PSA and medial parapetallar approach

This intervention will consist of using the ROSA alongside patient-specific alignment. The knee incision will be the same as the standard of care (medial parapatellar approach).

Comparatore attivo: ROSA PSA Subvastus Approach

Arm using the ROSA with PSA and medial subvastus approach

This intervention will consist of using the ROSA alongside patient-specific alignment. The knee incision will be an alternative, quad-sparing, subvastus approach.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Functional Outcome - Weight-bearing CT scan
Lasso di tempo: Pre-operation, 1-3 days post-op, 6-weeks post-op, and 1-year post-op

Patients will undergo a weight-bearing CT scan to examine implant migration and bone position in the knee.

Pre-operation, 1-3 days post-op, 6-weeks post-op, and 1-year post-op
Functional Outcome - 3D Ultrasound
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

Patients will undergo a 3D Ultrasound to measure the inflammatory characteristics including Synovial fluid and synovial thickness for fibrosis in the supra-patellar region of the knee

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op
Functional Outcome - Timed Up and Go test
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

Patients will undergo a Timed Up and Go (TUG) test. Patients will have to get up from a seated position, walk 10 feet, turn around and walk another 10 feet. This test is used to examine the function of the lower extremities. A time improvement of 2.27 Seconds will be considered clinically meaningful

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op
Patient health status - Knee Society Score
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

This will be done by comparing the Knee Society Score (KSS) Patient-reported outcome measurement questionnaire given to patients. The KSS questionnaire looks at several factors such as patient satisfaction (scale from 1-5, 5 being the best), Patient expectation (scale from 1-5, 5 being the best) and patient's pain during activities (scale from No pain to severe pain)

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op
Patient health status - EuroQuol Survey
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

This will be done by comparing the EuroQuol (EQ-5D) Patient-reported outcome measurement questionnaire given to patients. EQ-5D looks at the overall quality of life of a patient. The survey has 2 sections, the first asking the patient to best describe their health (Scale from Unable to perform the activity to no problem performing the activity) and an overall health assessment (scale 0-100, 100 being the best health you can imagine)

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op
Patient health status - Knee Injury and Osteoarthritis Outcome Score
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

This will be done by comparing the Knee Injury and Osteoarthritis Outcome score (KOOS) Patient-reported outcome measurement questionnaire given to patients. The KOOS survey looks at the pain and function of the operated knee. Patients will be asked questions about the pain they feel during activities (Scale from none-extreme) and the function of their joint (scale from none-extreme)

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op
Patient health status - Western Ontario and McMaster Universities Arthritis Index
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

This will be done by comparing the Western Ontario and McMaster Universities Arthritis Index (WOMAC) Patient-reported outcome measurement questionnaire given to patients. This survey will ask patients about the pain, stiffness and difficulty of using their knee. This survey is scaled from 0-4, 0 being none and 4 being extreme.

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op
Patient health status - Global Assessment
Lasso di tempo: Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

This will be done by comparing the UCLA Activity Score (UCLA) Patient-reported outcome measurement questionnaire given to patients. This survey assesses the activity level of patients on a scale from 0 - 10 with 10 being the patient regularly participates in impact sports.

Pre-operation, 6-weeks post-op, 3-months post-op and 1-year post-op

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Health Ecominics
Lasso di tempo: Pre-operation, 1-3 days post-op, 6-weeks post-op, 3-months post-op

Patients will be asked to fill out a cost-diary to determine if the new methods help reduce resource consumption

Pre-operation, 1-3 days post-op, 6-weeks post-op, 3-months post-op

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Brent Lanting, PhD, London Health Sciences Center

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

16 aprile 2024

Completamento primario (Stimato)

1 dicembre 2028

Completamento dello studio (Stimato)

1 dicembre 2028

Date di iscrizione allo studio

Primo inviato

2 gennaio 2024

Primo inviato che soddisfa i criteri di controllo qualità

12 febbraio 2024

Primo Inserito (Effettivo)

20 febbraio 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

21 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 122311

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .